The role of PON-2 and PON3 proteins in atherosclerosis

描述（由申请人提供）：对氧磷酶（PON）基因家族由三个家族成员组成，PON1， PON2和PONS。PON基因与包括动脉粥样硬化在内的几种炎症性疾病的发病机制有关。这三种PON蛋白都具有抗氧化特性和内酯酶活性；然而，PON蛋白的生理底物及其作用机制尚不清楚。我们的长期目标是了解PON2和PONS蛋白在生理和疾病中的作用。在上一个资助期内，我们开发了PON2和PONS基因的转基因/敲除小鼠模型，并首次提供了PON2和PONS蛋白抗动脉粥样硬化功能的体内证据。我们还证明氧化磷脂或脂质过氧化产物不是纯化PON酶的直接底物，这表明直接失活致动脉粥样硬化氧化磷脂不是PON蛋白的关键作用机制。我们提出PON蛋白的抗动脉粥样硬化活性是由于它们对一类未识别的参与LDL氧化的促炎脂内酯的活性。有趣的是，在一个非常令人兴奋的事件转折中，我们最近发现PON2和PONS蛋白降解革兰氏阴性细菌密度依赖的传感分子，称为酰基高丝氨酸内酯（AHL），参与革兰氏阴性毒力。ahl是脂内酯。由于革兰氏阴性毒力在包括动脉粥样硬化在内的炎症性疾病的病理中得到了很好的证实，因此我们提出，保护PON蛋白免受革兰氏阴性毒力因子（如ahl）和其他未知的促炎脂内酯介导的促炎途径的保护是PON蛋白的关键生理功能。我们将在PON2和PONS转基因/敲除小鼠模型中验证这一假设，有两个具体目的：1)研究PON2和PONS在缓解动脉粥样硬化发展中的分子机制和功能；2)确定PON2和PONS是否在宿主防御促炎群体感应分子和革兰氏阴性细菌感染中发挥作用。我们假设PON2和PONS是一类新的内酯酶，它们可以降解i)与动脉粥样硬化相关的致动脉粥样硬化性脂内酯，以及ii)与革兰氏阴性菌相关的促炎酰基同丝氨酸内酯，从而预防炎症性疾病的发病机制。

DESCRIPTION (provided by applicant): The paraoxonase (PON) gene family consists of three family members, PON1, PON2 and PONS. PON genes are implicated in the pathogenesis of several inflammatory diseases including atherosclerosis. All three PON proteins possess antioxidant properties and lactonase activities; however, the physiological substrates for PON proteins and their mechanism of action remain unknown. Our long-term goal is to understand the role of PON2 and PONS proteins in physiology and disease. During the last grant period, we have developed transgenic/knockout mouse models for PON2 and PONS genes, and provided the first in vivo evidence for the anti-atherogenic functions of PON2 and PONS proteins. We have also demonstrated that oxidized phospholipids or lipid peroxidation products are not direct substrates for purified PON enzymes, suggesting that direct inactivation of atherogenic oxidized phospholipids is not a key mechanism of action of PON proteins. We propose that the anti-atherogenic activities of PON proteins are a result of their activity towards a class of unidentified pro-inflammatory lipo-lactones that participate in LDL oxidation. Interestingly, in a very exciting turn of events, we recently discovered that PON2 and PONS proteins degrade gram-negative bacterial density-dependent sensing molecules termed acyl homoserine lactones (AHL) involved in gram-negative virulence. AHLs are lipo-lactones. Since gram-negative virulence is well established in the pathology of inflammatory diseases, including atherosclerosis, we propose that protection against pro-inflammatory pathways mediated by gram-negative virulence factors, such as AHLs, and other unidentified pro-inflammatory lipo-lactones, is a key physiological function of PON proteins. We will test this hypothesis in PON2 and PONS transgenic/knockout mouse models under two specific aims to 1) investigate the molecular mechanisms and function of PON2 and PONS in mitigating the development of atherosclerosis and 2) determine whether PON2 and PONS play a role in host defense against pro-inflammatory quorum sensing molecules and gram-negative bacterial infection. We hypothesize that PON2 and PONS are a novel class of lactonases that degrade i) atherogenic lipo-lactones associated with atherosclerosis, and ii) pro-inflammatory acyl homoserine lactones associated with gram-negative bacteria, thus preventing the pathogenesis of inflammatory diseases.